Therapeutic Targeting of LncRNAs with Next Generation Antisense Oligonucleotides in Cancer

Time: 11:00 am
day: Day One


  • Discussing the potential of targeting lncRNAs with next generation antisense drug for cancer
  • The technology also enables the rapid target validation of candidate lncRNAs in vitro and in vivo with the FLAME discovery engine
  • Identification and selection of clinical candidate Malat1rx for the treatment of cancer